Recollections of a Hepatitis Investigator—1940–1993

  • Saul Krugman
Conference paper


I am grateful to Dr. Nishioka and to his organizing committee for including me in the group of special invited guests to this Eighth Triennial International Symposium on Viral Hepatitis.


Viral Hepatitis Australia Antigen Heterologous Immunity Homologous Blood Product Vaccine Efficacy Study 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Neefe JR, Stokes J Jr, Reinhold JG, Lukens FIDW (1944) Hepatitis due to the injection of homologous blood products in human volunteers. J Clin Invest 23: 836–855PubMedCrossRefGoogle Scholar
  2. 2.
    Havens WP Jr, Ward R, Drill VA, Paul JR (1944) Experimental production of hepatitis by feeding icterogenic materials. Proc Soc Exp Biol 57: 206–208Google Scholar
  3. 3.
    Beeson PB (1943) Jaundice occurring one to four months after transfusion of blood or plasma: report of seven cases. JAMA 121: 1332–1334CrossRefGoogle Scholar
  4. 4.
    Krugman S, Giles JP (1970) Viral hepatitis: New light on an old disease. JAMA 212: 1019–1029PubMedCrossRefGoogle Scholar
  5. 5.
    Provost PJ, Hilleman MR (1978) An inactivated hepatitis A virus vaccine prepared from infected marmoset liver. Proc Soc Exp Biol Med 159: 201–203PubMedGoogle Scholar
  6. 6.
    Werzberger A, Mensch B, Kuter B, Brown L, Lewis J, Stirin R, Miller W, Shouval D, Wiens B, Calandra G, Ryan J, Provost P, Nalin D (1992) A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med 327: 453–457PubMedCrossRefGoogle Scholar
  7. 7.
    Tiollais P, Pourcel C, Dejean A (1985) The hepatitis B virus. Nature 317: 489–495PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 1994

Authors and Affiliations

  • Saul Krugman
    • 1
  1. 1.Department of PediatricsNew York University Medical CenterNew YorkUSA

Personalised recommendations